Home > Back to Publisher > Report Information

The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market

Takeda Pacific
July 1, 2002
138 Pages - SKU: TAK781284

Abstract Table of Contents Search inside this report Related Reports Buy by the Section

Countries covered: United States

The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market

The combination of the bioscience industry with the information technology (IT) industry is emerging as an exciting industry segment that is being called bio-IT. Bioinformatics and biocomputing are other terms that sometimes mean the same thing as bio-IT. Companies involved in this interesting industry have made it possible for several genomics companies to sequence sections of the human genome as well as do work in proteomics. The bio-IT market is emerging at an important time when the bioscience companies need enormous computing power to make sense of the flood of data that is being generated in drug discovery R&D labs. Ironically, this is also an important time for the IT industry, which is hungry for new customers in the slow economy. This report seeks to review all the key elements of this interesting and important market.

For sellers of IT, this report is a call to action for IT vendors to join into the emerging bio-IT market because opportunities are plentiful. This is unusual in a slow economy. Unlike other industries, the bioscience companies take a long term view of their business, have cash to spend on IT infrastructure, need much help from IT firms and are ready, willing and able to get started in expanding their IT infrastructures for their R&D operations. The report estimates that the bio-IT market will reach nearly $27.7 billion in 2005 with a CAGR of 31.7 percent.

Readers will learn that clusters of ordinary, yet powerful PCs running Windows or Linux can produce good computational results at a lower cost than was possible just a few years ago with big high performance computers. In-silico disease modeling is helping to predict potential drug outcomes. The web is being used to find much-needed clinical trails participants.

For potential customers, this report uses case studies of bio-IT deployments to provide a sense of what IT solutions bioscience companies require. Profiles of bio-IT vendors highlight basic information about vendors that are offering key solutions in the emerging bio-IT market. This report highlights what is driving the need for bio-IT infrastructure and why. Readers will learn about key business opportunities and the lessons learned from the bio-IT experts. This 138-page report uses more than 34 tables and figures to show the trends of this emerging field.

The Bio-IT Market
What the Bio-IT Market Represents
The Impact of Life Science Facts
Opportunity Roadmap for Bio-IT
Market Participants
Bioscience Systems Requirements
Technologies for Bio-IT
- Computers and Networks
- Storage Systems
- Application Software
- Nanotechnology
Drug Making Business Entering a Critical Time
Market Forces
Drivers of Bio-IT
- Drug Discovery R&D
- Scientific Development is Fast Moving
- Pharma R&D Can Afford Current Computer Power
- Pharma Companies Progressing To Next Bio-IT Steps
- High Computational Requirements for Proteomics R&D
- Other Developments
Bio-IT Software
- Genomic Data and Databases
- Databases for Protein Data
- Making Sense of All the Data
Bio-IT Solutions and Pharma R&D
Hardware Solutions
- Bioscience Network Storage Solution
- Big Pharma Genomics Computing Solution
- Massive Linux Compute Farm
- Government Institute Genomics Pattern Matching
Services Solutions
- IT Services Build Massive Compute Solution
- Children's Hospital Genomic Database and Services
Software Solutions
- Big Pharma In Silico Drug Discovery
- R&D Efficiency Gained with Analytical Solution
- Clinical Trial e-Business Patient Recruitment Solution
- Clinical Trial Management Solution for Drug Maker
The Bio-IT Market and Future Outlook
The Bio-IT Market and Industry Segments
- IT Services
- Servers
- Storage
- Software
- BioContent
Bio-IT Market Size by Segment, 2001~2005
Bio-IT Total Market Size
Forecast for Bio-IT R&D Market by Market Segments
- The Bio-IT "Services' Market Segment
- Bio-IT `Server' Market Segment Forecast
- Bio-IT `Storage' Market Segment Forecast
- Bio-IT `Software' Market Segment Forecast
- Bio-IT `BioContent' Market Segment Forecast
- Comparison of the Market Segment Forecasts
Bio-IT Future Trends
Overview of Past Trends
- Genomics Developments That Impact on Bio-IT
- Computer System Advancements
Future Directions
- IT Services
- Software
- Biocontent
- Servers
- Storage
Key Findings and Opportunities
Problems of Drug Discovery R&D and Bio-IT
- Difficulty of Converting Science Bottlenecks Into
- Computational Problems
Becoming a Low Profit Commodity
The Next Hot Areas of Bio-IT
- Need for Bigger and More Powerful Computers
- Clinical Trials, Bio-IT and e-Business
- Growing Interest in Personalized Medicine
Big Opportunities Emerging
- Role in Drug Discovery
- Data Storage and Management
- Consulting and e-Services Growing Fast
- Better Software
Summary
- Bio-IT Vendors to Become Partners with Pharmas
- Increase Chances of Pharma Success with Bio-IT
Company Profiles of Bio-IT Suppliers
BioContent Suppliers
- Celera Genomics Corporation
- Human Genome Sciences, Inc.
- Incyte Genomics, Inc.
- NuTec Sciences, Inc., Life Science Div.
Application Software Suppliers
- Accelrys, Inc.
- Cellomics, Inc.
- InforMax, Inc.
- Spotfire, Inc.
Hardware Systems Suppliers
- Compaq Computer Corporation
- IBM Corporation
- Paracel, Inc.
Bio-IT Service Suppliers
- Blackstone Computing
- Entigen Corporation
- Linux NetworX, Inc.
Systems Software Suppliers
- Red Hat Linux, Inc.
- Turbolinux, Inc.
Appendix 1 - Selected Suppliers
Appendix 2 - Bioscience Glossary

More United States Biopharmaceuticals Reports

The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment by AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical ...

Specialty Physicians Discuss their Opinions of the United States Biosimilars Market by Frost & Sullivan
The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of ...

Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020) by IMARC
With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. ...

Freedonia Focus on Biologics by Freedonia Focus
This report discusses US biologics demand for the years 2005 and 2010, with forecasts for 2015. Topics covered include product and application segmentation, ...

Biologics by Freedonia Group Inc
US demand to exceed $100 billion by 2015 Demand for biologics will exceed $100 billion in 2015, experiencing continuing strong growth following a decade of ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market

Share this report

Other tasks

Research Assistance

Related Markets

Biopharmaceuticals Reports

Free Alert Me service